Experiences with

Lymphocytic leukemia

https://www.patientpower.info/chronic-lymphocytic-leukemia/reframing-cll-a-clinical-trial-journey-down-under

The association of MRD status as a surrogate end point of clinical outcome in chronic lymphocytic leukemia (CLL) has not been established in the era of targeted agents.

Below are the notes: There is mild leukocytosis with lymphocytosis The lymphocytes comprise of predominantly small mature forms and a subpopulation with clumped chromatin highly suspicious for chronic lymphocytic leukemia. I know this isn't a dr site but is it time to visit him again?

Richter transformation involves the evolution of chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) into an aggressive lymphoma, Tedeschi and colleagues noted in their introduction.

We've had a few other posts recently regarding the TME; [i] • [/i]Targeting the tumor microenvironment for treating double refractory chronic leukemia posted by newyork917 https://healthunlocked.com/cllsupport/posts/private/150923620/targeting-the-tumor-microenvironment-for-treating-double-refractory-chronic-lymphocytic-leukemia

Hi all, I was intrigued by this article: Case Report of Unexpectedly Long Survival of Patient With Chronic Lymphocytic Leukemia: Why Integrative Methods Matter https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380985/ Has anyone explored this?

Ohio State Univeristy, FYI- REMISSION- 8 PLUS YEARS OUT https://www.patientpower.info/chronic-lymphocytic-leukemia/the-lowest-levels-of-cll-ive-ever-seen?

leukemia?

leukemia/small lymphocytic lymphoma (A-CLL/SLL) is a histologically aggressive subtype of CLL/SLL that lies in between conventional CLL/SLL (C-CLL/SLL) and Richter transformation (RT) on the biological spectrum.

Wierda, MD Anderson https://www.patientpower.info/chronic-lymphocytic-leukemia/asco-2024-your-cll-update

"Amoxicillin should be used with caution in patients with lymphocytic leukemia who are more susceptible to rashes (maculopapular skin reactions). Do you know anything? What other antibiotic could I substitute it for?

https://www.patientpower.info/chronic-lymphocytic-leukemia/ash-2023-unveils-a-new-gold-standard-for-cll-treatment Best, Pat

leukemia https://healthunlocked.com/cllsupport/posts/150659895/its-time-to-start-talking-about-ways-to-enhance-survivorship-for-those-with-chronic-lymphocytic-leukemia [i]"In recent years, survivorship strategies that aim to support and enhance the post treatment lives of cancer patients have

with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?

Lower cholesterol concentrations were reported in patients with chronic lymphocytic leukemia (CLL) and acute lymphocytic leukemia (ALL) than in healthy controls (108, 109), but a different report documented high cholesterol levels in patients with CLL (110).

https://www.patientpower.info/chronic-lymphocytic-leukemia/ash-2023-unveils-a-new-gold-standard-for-cll-treatment

Spotlight on Chronic Lymphocytic Leukemia (CLL) May 24, 2023 Nicole Lamanna, MD https://www.lls.org/patient-education-webcasts/spotlight-chronic-lymphocytic-leukemia-cll https://youtu.be/6KziJk3zQ_I Topics Covered: Emerging therapies and clinical trials for CLL Managing side effects Strategies

The frequency of TP53 aberrations in patients with chronic lymphocytic leukemia (CLL) is higher in those with unmutated immunoglobulin heavy variable (IGHV) genes.

Introducing the Phase I EUPLAGIA-1 study ([i]EudraCT 2021-003815-25), which investigated GLPG5201, a CD19 CAR T-cell therapy, in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and Richter’s transformation (RT).

I found this article interesting, since I am in the active surveillance camp… https://powerfulpatients.org/2023/08/07/why-is-early-stage-chronic-lymphocytic-leukemia-treatment-delayed/